Interestingly, therapeutic RAAS inhibition showed a clear trend towards improved OS within the group of patients with pure dHGP, whilst the group of patients with a not pure dHGP exhibited no differences in OS rates (Fig.
← all excerpts
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
1
—
—